Insider · CIK 0001267490

WILSON KAREN J

Reports to the SEC for 7 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001267490

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.8K sh	—	—	21,750
2026-06-17	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.3K sh	—	—	15,250
2026-06-12	SERSerina Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.77	+$8,850	10,100
2026-06-11	SERSerina Therapeutics, Inc.P Purchase	Director	PPurchase	+5,100 sh	$1.75	+$8,899.5	5,100
2026-05-22	SERSerina Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$1.93	+$19.3K	20,000
2026-05-21	SERSerina Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$1.77	+$17.7K	10,000
2025-11-13	LAVA Therapeutics NVD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2025-11-13	LAVA Therapeutics NVShare Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.4K sh	—	—	0
2025-11-07	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2025-05-19	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,900 sh	—	—	7,900
2025-02-13	LAVA Therapeutics NVCommon Shares (Right to Buy)A Award	Director	AAward	+33.4K sh	—	—	33,390
2025-01-14	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-11-21	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2023-12-28	ELTXElicio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2022-06-09	ELTXElicio Therapeutics, Inc. · Common StockA Award	Director	AAward	+15K sh	—	—	15,000
2021-06-16	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.1K sh	—	—	15,097
2021-03-08	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-02-09	ELTXElicio Therapeutics, Inc.C Conversion	Director	CConversion	+18.7K sh	$11.57	+$217K	18,718
2021-02-09	ELTXElicio Therapeutics, Inc. · Convertible Promissory NoteC Conversion	Director	CConversion	—	—	—	0
2020-08-25	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+65.7K sh	—	—	65,700
2019-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−276 sh	$135.82	−$37.5K	18,687
2019-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−302 sh	$135.82	−$41K	18,385
2019-02-28	JAZZJazz Pharmaceuticals plcA Award	SVP, Finance & PAO	AAward	+3,500 sh	—	—	18,963
2019-02-28	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	SVP, Finance & PAO	AAward	+576 sh	—	—	576
2019-02-28	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)A Award	SVP, Finance & PAO	AAward	+8,174 sh	—	—	8,174
2019-02-26	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−230 sh	$127.76	−$29.4K	15,463
2019-02-25	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−310 sh	$126.25	−$39.1K	15,693
2018-05-11	JAZZJazz Pharmaceuticals plcS Sale	SVP, Finance & PAO	SSale	−3,706 sh	$165.00	−$611K	15,811
2018-05-11	JAZZJazz Pharmaceuticals plcS Sale	SVP, Finance & PAO	SSale	−54 sh	$165.00	−$8,910.27	15,757
2018-04-10	JAZZJazz Pharmaceuticals plcS Sale	SVP, Finance & PAO	SSale	−3,899 sh	$155.00	−$604K	19,517
2018-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−302 sh	$143.39	−$43.3K	23,416
2018-03-01	JAZZJazz Pharmaceuticals plcA Award	SVP, Finance & PAO	AAward	+3,200 sh	—	—	23,718
2018-03-01	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	SVP, Finance & PAO	AAward	+681 sh	—	—	681
2018-03-01	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)A Award	SVP, Finance & PAO	AAward	+7,319 sh	—	—	7,319
2018-02-27	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−324 sh	$143.80	−$46.6K	20,518
2018-02-26	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−537 sh	$147.44	−$79.2K	20,842
2017-04-27	JAZZJazz Pharmaceuticals plcS Sale	SVP, Finance & PAO	SSale	−1,275 sh	$160.00	−$204K	21,133
2017-04-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	+4,750 sh	$59.13	+$281K	27,158
2017-04-10	JAZZJazz Pharmaceuticals plcS Sale	SVP, Finance & PAO	SSale	−4,750 sh	$152.24	−$723K	22,408
2017-04-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	+6,708 sh	$46.83	+$314K	29,116
2017-04-10	JAZZJazz Pharmaceuticals plcS Sale	SVP, Finance & PAO	SSale	−6,708 sh	$152.24	−$1.02M	22,408
2017-04-10	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	−6,708 sh	—	—	0
2017-04-10	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	−4,750 sh	—	—	0
2017-03-08	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	+2,896 sh	$46.83	+$136K	21,658
2017-03-08	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	+750 sh	$59.13	+$44.3K	22,408
2017-03-08	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)M Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	−2,896 sh	—	—	0
2017-03-08	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)M Exercise/Conversion	SVP, Finance & PAO	MExercise/Conversion	−750 sh	—	—	0
2017-03-06	JAZZJazz Pharmaceuticals plcF Tax Payment	SVP, Finance & PAO	FTax Payment	−563 sh	$132.81	−$74.8K	18,762
2017-03-02	JAZZJazz Pharmaceuticals plcA Award	SVP, Finance & PAO	AAward	+3,500 sh	—	—	19,325
2017-03-02	JAZZJazz Pharmaceuticals plc · Incentive Stock Option (right to buy)A Award	SVP, Finance & PAO	AAward	+969 sh	—	—	969

Recent filings

Accepted (ET)
Sep 24
WILSON KAREN J0001267490-26-000010
SEC(opens sec.gov)
Jun 224
WILSON KAREN J0001267490-26-000008
SEC(opens sec.gov)
Jun 154
WILSON KAREN J0001267490-26-000006
SEC(opens sec.gov)
May 264
WILSON KAREN J0001267490-26-000004
SEC(opens sec.gov)
Nov 174
WILSON KAREN J0001267490-25-000006
SEC(opens sec.gov)
Nov 104
WILSON KAREN J0001267490-25-000003
SEC(opens sec.gov)
May 204
WILSON KAREN J0001601485-25-000086
SEC(opens sec.gov)
Feb 184
WILSON KAREN J0001415889-25-004532
SEC(opens sec.gov)
Jan 154
WILSON KAREN J0001708599-25-000009
SEC(opens sec.gov)
Nov 254
WILSON KAREN J0001601485-24-000101
SEC(opens sec.gov)
Dec 294
WILSON KAREN J0001140361-23-060237
SEC(opens sec.gov)
Jun 134
WILSON KAREN J0001601485-22-000051
SEC(opens sec.gov)
Jun 174
WILSON KAREN J0001437749-21-015113
SEC(opens sec.gov)
Mar 104
WILSON KAREN J0001567619-21-005971
SEC(opens sec.gov)
Feb 114
WILSON KAREN J0001567619-21-003192
SEC(opens sec.gov)
Aug 274
WILSON KAREN J0001437749-20-018801
SEC(opens sec.gov)

Companies

Address

C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501

BOSTON, MA, 02210